SCHEMBL18994710

SCHEMBL18994710

C=C1CN(CCC)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL268470 0.68 KMT2A (0.61)
SCHEMBL10630436 0.68 MAPT (0.61)
SCHEMBL18827249 0.63
SCHEMBL8029443 0.61 ALOX5 (0.41)
SCHEMBL13563423 0.61 DRD2 (0.41)
SCHEMBL2632719 0.59 ALDH1A1 (0.68)
SCHEMBL5707893 0.59 TOP2A (0.48)
SCHEMBL31147144 0.59 DRD2 (0.34)
SCHEMBL11681717 0.59
SCHEMBL28547061 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227461-A1 SELECTIVE CDK4/6 INHIBITOR CANCER THERAPEUTICS LUNELLA BIOTECH, INC. (CA) 2023-07-20 US disclosed
US-9682939-B2 Compositions and methods for modulating farnesoid X receptors NOVARTIS AG (CH) 2017-06-20 US disclosed